Xvivo Perfusion AB
STO:XVIVO

Watchlist Manager
Xvivo Perfusion AB Logo
Xvivo Perfusion AB
STO:XVIVO
Watchlist
Price: 453 SEK 0.11% Market Closed
Market Cap: 14.3B SEK
Have any thoughts about
Xvivo Perfusion AB?
Write Note

Gross Margin
Xvivo Perfusion AB

74.4%
Current
73%
Average
47.4%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
74.4%
=
Gross Profit
558.5m
/
Revenue
750.6m

Gross Margin Across Competitors

Country SE
Market Cap 14.3B SEK
Gross Margin
74%
Country JP
Market Cap 7T JPY
Gross Margin
86%
Country CH
Market Cap 37.8B CHF
Gross Margin
55%
Country DK
Market Cap 205.9B DKK
Gross Margin
68%
Country US
Market Cap 16B USD
Gross Margin
70%
Country CN
Market Cap 53.9B CNY
Gross Margin
73%
Country CA
Market Cap 7B USD
Gross Margin
61%
Country UK
Market Cap 5.3B GBP
Gross Margin
56%
Country CH
Market Cap 5.2B CHF
Gross Margin
34%
Country US
Market Cap 5.9B USD
Gross Margin
47%
Country KR
Market Cap 8T KRW
Gross Margin
11%

Profitability Report

View the profitability report to see the full profitability analysis for Xvivo Perfusion AB.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
74.4%
=
Gross Profit
558.5m
/
Revenue
750.6m
What is the Gross Margin of Xvivo Perfusion AB?

Based on Xvivo Perfusion AB's most recent financial statements, the company has Gross Margin of 74.4%.